ArticleMedical oncology (Northwood, London, England)2021

Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance.

Luca Triggiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.